(Q77593116)
Statements
Priming or tolerization of the B- and Th2-dependent immune response by the oral administration of OVA-DNP is determined by the antigen dosage (English)
Franco L
Benedetti R
Ferek GA
Massouh E
1 November 1998
scientific article published on 01 November 1998